Bio-Techne

Company Snapshot

Founded: 1976
Entity Type: Public
Employees: 3,100
Region: U.S.
Revenue: $1,159.1 Millions
Revenue Year: 2023
Segment: Protein Sciences
Headquarter: Minnesota, U.S.
Key Geographics: U.S., Europe, Middle-East, Africa, Asia-Pacific, Rest of the World
Corporate Address: 614 McKinley Place N.E, Minneapolis, Minnesota 55413, U.S. Tel. +1 612-379-8854 www.bio-techne.com

Company Overview

Bio-Techne is a developer, manufacturer, and supplier of life science reagents, instruments, and services for research, diagnostics, and bioprocessing markets. The company manages the business in two operating segments –Protein Sciences and Diagnostics and Genomics.

The Protein Sciences segment comprises two divisions: Reagent Solutions and Analytical Solutions. The Reagent Solutions division provides specialized proteins and cell selection technologies for research use under cGMP. Key product brands include Tocris Biosciences, Novus Biologicals, and R&D Systems. Novus Biologicals offers exosome isolation and detection services.

The Diagnostics and Genomics segment has three divisions: Molecular Diagnostics, Spatial Biology, and Diagnostics Reagents. The Molecular Diagnostics division offers products and services through its Exosome Diagnostics and Asuragen brands. Bio-Techne’s Exosome Diagnostics business (ExosomeDx) develops and sells exosome-based diagnostic tests.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Bio-Techne In Reports

Proteomics: Technologies and Global Markets

According to BCC Research proteomics market includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

Single-Cell Genomics and Proteomics: Emerging Technologies and Markets

BCC Research Report: Dive into Single-Cell Genomics and Proteomics Market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

Global Markets for Media, Sera and Reagents in Biotechnology

BCC Research Report: Dive into Media Sera and Reagents in Biotechnology market report considers 2023 as the base year and the forecast years 2024 through 2029.

Company's Business Segments

  • Protein Sciences : Proteomic analytical tools, both manual and automated, developer and manufacturer of high-quality biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy.
  • Diagnostics and Genomics : Develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications.

Applications/End User Industries

  • Academia
  • Researchers
  • Companion Diagnostics
  • Neuroscience
  • Immunology
  • Oncology
  • Cancer Research
  • pharmaceutical and biotech companies
  • research organizations
  • diagnostic
  • companion diagnostic
  • therapeutic customers
  • cell- and gene-based therapies
  • Targeted Protein Degradation
  • Metabolism
  • Epigenetics
  • Cell and Gene Therapy Manufacturing
  • Protein Bioprocessing
  • Immunoassay
  • Vaccine Development
  • Recombinant Proteins